Generation and Characterization of a Protective Monoclonal Antibody toPseudomonas aeruginosaPcrV
Author(s) -
Dara W. Frank,
Amy J. Vallis,
Jeanine P. WienerKronish,
Arup RoyBurman,
Edward G. Spack,
Brian P. Mullaney,
Mehdi Megdoud,
James D. Marks,
Robert B. Fritz,
Teiji Sawa
Publication year - 2002
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/341069
Subject(s) - pseudomonas aeruginosa , microbiology and biotechnology , monoclonal antibody , polyclonal antibodies , epitope , type three secretion system , biology , antibody , virulence , virology , immunology , bacteria , gene , biochemistry , genetics
Pseudomonas aeruginosa is a gram-negative pathogen causing life-threatening infections. Lung injury and the development of sepsis depend largely on the expression of type III secretion system (TTSS) virulence. TTSS functions as a molecular syringe to deliver toxins directly to the cytosol of cells, inhibit innate immune mechanisms, and prevent bacterial clearance. Polyclonal antibodies that bind to PcrV of P. aeruginosa inhibit the delivery of type III toxins and enhance the clearance of bacteria during acute lung infections. PcrV is a homologue of LcrV, a protective antigen in the Yersinia TTSS and an integral component of TTSS. In this study, a murine monoclonal antibody (MAb) to PcrV was generated: MAb 166, which is protective against P. aeruginosa when coinstilled with the bacterial inoculum or intraperitoneally transferred to mice. Fab fragments from MAb 166 prevent sepsis and death. The epitope bound by MAb 166 was mapped to the carboxyl-terminus of PcrV.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom